Biotechnology Pfizer’s Respiratory Syncytial Virus Vaccine Maintains Staying Power In Older Adults Through 2nd RSV season, Study Finds – Pfizer (NYSE:PFE) Read more
Biotechnology Moderna Stock Q4 Earnings Preview: RSV mRNA Vaccine Scrutiny, Diminishing Spikevax Revenue, FDA Approval In Focus – Moderna (NASDAQ:MRNA) Read more
Commodities US is ’18 months or so’ away from finding bird flu vaccine, says agriculture secretary Reuters via biedexmarkets.com Read more
Biotechnology Chikungunya Vaccine Maker Valneva Secures Non Dilutive Funding To Develop/Expand Its Clinical Pipeline – Valneva (NASDAQ:VALN) Read more
Biotechnology Novavax’s Malaria Vaccine Gets WHO Prequalification, Has Potential Of Being An Affordable Option – Novavax (NASDAQ:NVAX) Read more
Biotechnology GSK Upgrades Long-Term Outlook After Q4 Performance, Shingrix Vaccine And Newly Launched RSV Vaccine Shine GSK Shares Are Trading Higher Today – Here’s Why – GSK (NYSE:GSK) Read more